CENPA and therapy-related myeloid neoplasm: Most of the reports support the idea that CENP-A levels can effectively predict patients’ pathological TMN stage and their recurrence-free survival due to the evidence provided by different research groups, confirming the high expression of CENP-A from their IHC and many other staining experiments [190,199].